ARTICLE | Company News
Cell Medica, Baylor deal
January 10, 2011 8:00 AM UTC
The college granted Cell Medica an exclusive, worldwide license to develop and commercialize its Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTLs). The product has completed a Phase I/...